Lymph nodes are a primary site of metastatic spread for almost all malignant tumors. Tracking changes to lymph node burden and lymph node staging has become increasingly important in diagnostics, as evidenced by the recent revision of RECIST criteria in early 2009. Clinicians recognize that lymph node staging is central to cancer patients’ treatment course and care management.
If you enjoy this content, please share it with a colleague
- Read more about CAD Surpasses Limits of Lymph Node Imaging
- Log in or register to post comments